Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 4Lymphoid 1Head & Neck 1Genitourinary 1Endocrine 1Classical hematology 1

Conditions

Neuroendocrine Tumors 531Multiple Endocrine Neoplasia Type 1 187Pituitary Neoplasms 186Thyroid Cancer, Papillary 178Pheochromocytoma 152Carcinoma, Neuroendocrine 140Thyroid Neoplasms 130Neoplasms 107Carcinoid Tumor 99Paraganglioma 98Adrenocortical Carcinoma 92Thyroid Carcinoma, Anaplastic 82Pancreatic Neoplasms 69Neoplasm Metastasis 67Insulinoma 61Adrenal Gland Neoplasms 61Gastro-enteropancreatic neuroendocrine tumor 58Carcinoma, Medullary 58Adenocarcinoma, Follicular 58Carcinoma, Non-Small-Cell Lung 57Breast Neoplasms 56Adenoma, Islet Cell 56Lung Neoplasms 50Sarcoma 49Colorectal Neoplasms 49Carcinoma, Renal Cell 49Melanoma 47Small Cell Lung Carcinoma 45Prostatic Neoplasms 44Head and Neck Neoplasms 43

Interventions

Visual Field Tests 1Visual Acuity 1Diffusion Tensor Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Vision Disorders × Endocrine × Clear all
NCT03591315 2018-07-23

Clinical Study of Structural and Functional Evaluation of the Visual Pathway

Xiangya Hospital of Central South University

Unknown
60 enrolled
Endocrine

Pituitary Neoplasms, Vision Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡